Lista de obras - Clara Natoli - Dominio Público Uruguay

"Back to a false normality": new intriguing mechanisms of resistance to PARP inhibitors

artículo científico publicado en 2016

"Triple positive" early breast cancer: an observational multicenter retrospective analysis of outcome.

artículo científico publicado en 2016

90K (MAC-2 BP) gene expression in breast cancer and evidence for the production of 90K by peripheral-blood mononuclear cells

artículo científico publicado en 1998

90K (Mac-2 BP) and galectins in tumor progression and metastasis

artículo científico publicado en 2004

A Case of Stage I Vulvar Squamous Cell Carcinoma with Early Relapse and Rapid Disease Progression

scientific article published on 03 July 2019

A Real-World Multicentre Retrospective Study of Paclitaxel-Bevacizumab and Maintenance Therapy as First-Line for HER2-Negative Metastatic Breast Cancer.

artículo científico publicado en 2016

A multicenter REtrospective observational study of first-line treatment with PERtuzumab, trastuzumab and taxanes for advanced HER2 positive breast cancer patients. RePer Study

artículo científico publicado en 2018

A multicenter study of body mass index in cancer patients treated with anti-PD-1/PD-L1 immune checkpoint inhibitors: when overweight becomes favorable

artículo científico publicado en 2019

A multidisciplinary group for prostate cancer management: A single institution experience

artículo científico publicado en 2017

A phase II study of dose-dense epirubicin plus cyclophosphamide followed by docetaxel plus capecitabine and pegfilgrastim support as preoperative therapy for patients with stage II, IIIA breast cancer

artículo científico publicado en 2007

A retrospective multicentric observational study of trastuzumab emtansine in HER2 positive metastatic breast cancer: a real-world experience

artículo científico publicado en 2017

Abiraterone Acetate for Treatment of Metastatic Castration-resistant Prostate Cancer in Chemotherapy-naive Patients: An Italian Analysis of Patients' Satisfaction

artículo científico publicado en 2017

Adherence to hormonal deprivation therapy in prostate cancer in clinical practice: a retrospective, single-center study

scientific article published on 19 September 2018

An epigenetic approach to pancreatic cancer treatment: the prospective role of histone deacetylase inhibitors

artículo científico

Analysis of the hippo transducers TAZ and YAP in cervical cancer and its microenvironment.

artículo científico publicado en 2016

Beyond evidence-based data: scientific rationale and tumor behavior to drive sequential and personalized therapeutic strategies for the treatment of metastatic renal cell carcinoma

artículo científico publicado en 2016

Body Mass Index and Treatment Outcomes in Metastatic Breast Cancer Patients Treated With Eribulin.

artículo científico publicado en 2015

Body mass index in HER2-negative metastatic breast cancer treated with first-line paclitaxel and bevacizumab.

artículo científico publicado en 2018

Body mass index modifies the relationship between γ-H2AX, a DNA damage biomarker, and pathological complete response in triple-negative breast cancer.

artículo científico publicado en 2017

Breast cancer "tailored follow-up" in Italian oncology units: a web-based survey

artículo científico publicado en 2014

Breast cancer follow-up strategies in randomized phase III adjuvant clinical trials: a systematic review

artículo científico publicado en 2013

Changes of topoisomerase IIalpha expression in breast tumors after neoadjuvant chemotherapy predicts relapse-free survival.

artículo científico publicado en 2006

Chemotherapy-induced nausea and vomiting in Italian cancer centers: results of CINVDAY, a prospective, multicenter study

artículo científico publicado en 2014

Circulating Cancer Stem Cell-Derived Extracellular Vesicles as a Novel Biomarker for Clinical Outcome Evaluation

scientific article published on 18 November 2019

Circulating autoantibodies to LGALS3BP: a novel biomarker for cancer

artículo científico publicado en 2013

Circulating immunostimulatory protein 90K and soluble interleukin-2-receptor in human ovarian cancer

artículo científico publicado en 1996

Combination of peripheral neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio is predictive of pathological complete response after neoadjuvant chemotherapy in breast cancer patients

artículo científico publicado en 2019

Combinations of biological response modifiers: rationale and clinical responses

artículo científico publicado en 1992

Comparison between CaGene 5.1 and 6.0 for BRCA1/2 mutation prediction: a retrospective study of 150 BRCA1/2 genetic tests in 517 families with breast/ovarian cancer.

artículo científico publicado en 2016

Corrigendum to "Circulating Cancer Stem Cell-Derived Extracellular Vesicles as a Novel Biomarker for Clinical Outcome Evaluation"

artículo científico publicado en 2020

Cyclooxygenase-independent induction of p21WAF-1/cip1, apoptosis and differentiation by L-745,337, a selective PGH synthase-2 inhibitor, and salicylate in HT-29 cells

artículo científico publicado en 1999

DNA and S-phase fraction analysis by flow cytometry in prostate cancer. Clinicopathologic implications

scientific article published on 01 February 1993

DNA ploidy and S-phase fraction in pulmonary carcinoids

scientific article published on 01 January 1992

Differential effect on TCR:CD3 stimulation of a 90-kD glycoprotein (gp90/Mac-2BP), a member of the scavenger receptor cysteine-rich domain protein family

artículo científico publicado en 1998

Distinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+ breast cancer and degree of benefit from novel anti-HER2 agents in the real world setting

artículo científico publicado en 2019

Dynamic test with recombinant interferon-alpha-2b: effect on 90K and other tumour-associated antigens in cancer patients without evidence of disease.

artículo científico publicado en 1993

Effect of targeted agents on the endocrine response of breast cancer in the neoadjuvant setting: a systematic review

artículo científico publicado en 2015

Effect of thyroid hormones on androgen responsiveness in a mammary tumor cell line

scientific article published on 01 December 1981

Effectiveness and response predictive factors of erlotinib in a non-small cell lung cancer unselected European population previously treated: a retrospective, observational, multicentric study

artículo científico publicado en 2012

Effectiveness of neoadjuvant trastuzumab and chemotherapy in HER2-overexpressing breast cancer

artículo científico publicado en 2013

Effects of repurposed drug candidates nitroxoline and nelfinavir as single agents or in combination with erlotinib in pancreatic cancer cells

scientific article published on 21 September 2018

Effects of type-I and -II interferons on 90K antigen expression in ovarian carcinoma cells

scientific article published on 01 December 1994

Elevated serum levels of 90K/MAC-2 BP predict unresponsiveness to alpha-interferon therapy in chronic HCV hepatitis patients.

artículo científico publicado en 1996

Eribulin in Triple Negative Metastatic Breast Cancer: Critic Interpretation of Current Evidence and Projection for Future Scenarios

scientific article published on 12 October 2019

Estrogen binding by neoplastic human thymus cytosol

artículo científico publicado en 1980

Expression of glycoprotein 90K in human malignant pleural mesothelioma: correlation with patient survival.

artículo científico publicado en 2002

Expression of the 90K Tumor-Associated Protein in Benign and Malignant Melanocytic Lesions

scientific article published on 01 July 2002

Extraordinary and prolonged erlotinib-induced clinical response in a patient with EGFR wild-type squamous lung cancer in third-line therapy: a case report.

artículo científico publicado en 2017

Family history of cancer as surrogate predictor for immunotherapy with anti-PD1/PD-L1 agents: preliminary report of the FAMI-L1 study

artículo científico publicado en 2018

Fulvestrant 500 milligrams as endocrine therapy for endocrine sensitive advanced breast cancer patients in the real world: the Ful500 prospective observational trial.

artículo científico publicado en 2017

Galectin-3 overexpression protects from apoptosis by improving cell adhesion properties

artículo científico publicado en 2000

Galectin-3 overexpression protects from cell damage and death by influencing mitochondrial homeostasis.

artículo científico publicado en 2000

Galectins and their ligands: amplifiers, silencers or tuners of the inflammatory response?

artículo científico publicado en 2002

Growth promoting influences of estradiol, epidermal growth factor, and insulin on human breast cancer: Evidence for differential mechanism of action on tumor cells in vitro

article

Gynaecomastia with cimetidine

artículo científico publicado en 1977

High expression of 90K (Mac-2 BP) is associated with poor survival in node-negative breast cancer patients not receiving adjuvant systemic therapies

scientific article published on 01 January 2009

Human milk 90K (Mac-2 BP): possible protective effects against acute respiratory infections

artículo científico publicado en 1999

Identification of subgroups of early breast cancer patients at high risk of nonadherence to adjuvant hormone therapy: results of an Italian survey

artículo científico publicado en 2014

Impact of BMI on HER2+ metastatic breast cancer patients treated with pertuzumab and/or trastuzumab emtansine. Real-world evidence

artículo científico publicado en 2020

Inhibition of tumor growth and angiogenesis by SP-2, an anti-lectin, galactoside-binding soluble 3 binding protein (LGALS3BP) antibody

artículo científico publicado en 2014

Interleukin-30 Promotes Breast Cancer Growth and Progression

artículo científico publicado en 2016

Is the skin a sanctuary for breast cancer cells during treatment with anti-HER2 antibodies?

artículo científico publicado en 2015

Lack of Expression of Galectin-3 Is Associated With a Poor Outcome in Node-Negative Patients With Laryngeal Squamous-Cell Carcinoma

artículo científico publicado en 2002

Lack of mother-to-child HIV-1 transmission is associated with elevated serum levels of 90 K immune modulatory protein

article

Long-term outcome of breast cancer patients with pathologic N3a lymph node stage.

artículo científico publicado en 2017

Long-term outcome of neoadjuvant endocrine therapy with aromatase inhibitors in elderly women with hormone receptor-positive breast cancer.

artículo científico publicado en 2014

Long-term outcome of neoadjuvant systemic therapy for locally advanced breast cancer in routine clinical practice

artículo científico publicado en 2012

Long-term performance of risk scores for venous thromboembolism in ambulatory cancer patients

artículo científico publicado en 2019

Measurement of a breast cancer associated antigen detected by monoclonal antibody SP-2 in sera of cancer patients

scientific article published on 01 April 1988

Meta-analysis of phase III trials of docetaxel alone or in combination with chemotherapy in metastatic breast cancer

artículo científico publicado en 2012

Multicentric retrospective analysis of platinum-pemetrexed regimens as first-line therapy in non-squamous non-small cell lung cancer patients: A "snapshot" from clinical practice.

artículo científico publicado en 2017

Neoadjuvant Chemotherapy In Triple-Negative Breast Cancer: A Multicentric Retrospective Observational Study In Real-Life Setting.

artículo científico

Outcomes of HER2-positive early breast cancer patients in the pre-trastuzumab and trastuzumab eras: a real-world multicenter observational analysis. The RETROHER study

artículo científico publicado en 2014

PD-L1 expression as predictive biomarker in patients with NSCLC: a pooled analysis

artículo científico publicado en 2016

Palbociclib plus endocrine therapy in HER2 negative, hormonal receptor-positive, advanced breast cancer: A real-world experience

artículo científico publicado en 2018

Predictive significance of DNA damage and repair biomarkers in triple-negative breast cancer patients treated with neoadjuvant chemotherapy: An exploratory analysis

artículo científico publicado en 2015

Prognostic Value of a Novel Interferon-inducible 90K Tumor Antigen

scientific article published on 01 April 1996

Prognostic relevance of DNA damage and repair biomarkers in elderly patients with hormone-receptor-positive breast cancer treated with neoadjuvant hormone therapy: evidence from the real-world setting

artículo científico publicado en 2019

Prognostic significance of K-Ras mutation rate in metastatic colorectal cancer patients.

artículo científico publicado en 2015

Prognostic value of a novel circulating serum 90K antigen in breast cancer.

artículo científico publicado en 1994

Purification and characterization of a 90 kDa protein released from human tumors and tumor cell lines

artículo científico publicado en 1993

Recombinant alpha-2b-interferon enhances the circulating levels of a 90-kilodalton (K) tumor-associated antigen in patients with gynecologic and breast malignancies

scientific article published on 01 March 1990

Recombinant human leukocyte interferon-alpha 2b stimulates the synthesis and release of a 90K tumor-associated antigen in human breast cancer cells

artículo científico publicado en 1988

Relationship and Predictive Role of the Dual Expression of FGFR and IL-8 in Metastatic Renal Cell Carcinoma Treated with Targeted Agents

artículo científico publicado en 2018

Relationship between the tumour-associated antigen 90K and cytokines in the circulation of persons infected with human immunodeficiency virus

artículo científico publicado en 1994

Reply to Kadri Altundag: Do cut-off values of lymph node ratio and presence of perineural invasion affect survival in breast cancer patients with pathologic N3a lymph node stage?

artículo científico publicado en 2017

Risk factors for locoregional disease recurrence after breast-conserving therapy in patients with breast cancer treated with neoadjuvant chemotherapy: An international collaboration and individual patient meta-analysis

scientific article published on 03 May 2018

Rivaroxaban for Cancer-associated Cardiac Thrombosis

artículo científico publicado en 2015

Role of Hydroxamate-Based Histone Deacetylase Inhibitors (Hb-HDACIs) in the Treatment of Solid Malignancies

artículo científico publicado en 2013

Safety analysis, association with response and previous treatments of everolimus and exemestane in 181 metastatic breast cancer patients: A multicenter Italian experience

artículo científico publicado en 2016

Safety and efficacy of abiraterone acetate in chemotherapy-naive patients with metastatic castration-resistant prostate cancer: an Italian multicenter "real life" study

artículo científico publicado en 2017

Skin toxicity evaluation in patients treated with cetuximab for metastatic colorectal cancer: a new tool for more accurate comprehension of quality of life impacts.

artículo científico publicado en 2017

Targeting immune response with therapeutic vaccines in premalignant lesions and cervical cancer: hope or reality from clinical studies

scientific article published on 11 April 2016

The Hippo transducer TAZ as a biomarker of pathological complete response in HER2-positive breast cancer patients treated with trastuzumab-based neoadjuvant therapy.

artículo científico publicado en 2014

The comparison of outcomes from tyrosine kinase inhibitor monotherapy in second- or third-line for advanced non-small-cell lung cancer patients with wild-type or unknown EGFR status

scientific article published on 16 March 2016

The immune stimulatory protein 90K increases major histocompatibility complex class I expression in a human breast cancer cell line.

artículo científico publicado en 1996

The resistance related to targeted therapy in malignant pleural mesothelioma: Why has not the target been hit yet?

artículo científico publicado en 2016

Topographic expression of the Hippo transducers TAZ and YAP in triple-negative breast cancer treated with neoadjuvant chemotherapy

artículo científico publicado en 2016

Triple positive breast cancer: a distinct subtype?

artículo científico publicado en 2014

Triplet chemotherapy in patients with metastatic colorectal cancer: toward the best way to safely administer a highly active regimen in clinical practice.

artículo científico

Tumor-associated antigen 90K activates myelomonocytic cell line THP-1.

artículo científico publicado en 1996

Tumor-derived microvesicles: the metastasomes.

artículo científico publicado en 2012

Tyrosine Kinase Inhibitors

artículo científico publicado en 2010

Viral and host factors in determining response of relapsers with chronic hepatitis C to retreatment with interferon

artículo científico publicado en 1999

What links BRAF to the heart function? New insights from the cardiotoxicity of BRAF inhibitors in cancer treatment

artículo científico publicado en 2015

Lista de obras de Clara Natoli

"Back to a false normality": new intriguing mechanisms of resistance to PARP inhibitors

"Triple positive" early breast cancer: an observational multicenter retrospective analysis of outcome.

90K (MAC-2 BP) gene expression in breast cancer and evidence for the production of 90K by peripheral-blood mononuclear cells

90K (Mac-2 BP) and galectins in tumor progression and metastasis

A Case of Stage I Vulvar Squamous Cell Carcinoma with Early Relapse and Rapid Disease Progression

A Real-World Multicentre Retrospective Study of Paclitaxel-Bevacizumab and Maintenance Therapy as First-Line for HER2-Negative Metastatic Breast Cancer.

A multicenter REtrospective observational study of first-line treatment with PERtuzumab, trastuzumab and taxanes for advanced HER2 positive breast cancer patients. RePer Study

A multicenter study of body mass index in cancer patients treated with anti-PD-1/PD-L1 immune checkpoint inhibitors: when overweight becomes favorable

A multidisciplinary group for prostate cancer management: A single institution experience

A phase II study of dose-dense epirubicin plus cyclophosphamide followed by docetaxel plus capecitabine and pegfilgrastim support as preoperative therapy for patients with stage II, IIIA breast cancer

A retrospective multicentric observational study of trastuzumab emtansine in HER2 positive metastatic breast cancer: a real-world experience

Abiraterone Acetate for Treatment of Metastatic Castration-resistant Prostate Cancer in Chemotherapy-naive Patients: An Italian Analysis of Patients' Satisfaction

Adherence to hormonal deprivation therapy in prostate cancer in clinical practice: a retrospective, single-center study

An epigenetic approach to pancreatic cancer treatment: the prospective role of histone deacetylase inhibitors

Analysis of the hippo transducers TAZ and YAP in cervical cancer and its microenvironment.

Beyond evidence-based data: scientific rationale and tumor behavior to drive sequential and personalized therapeutic strategies for the treatment of metastatic renal cell carcinoma

Body Mass Index and Treatment Outcomes in Metastatic Breast Cancer Patients Treated With Eribulin.

Body mass index in HER2-negative metastatic breast cancer treated with first-line paclitaxel and bevacizumab.

Body mass index modifies the relationship between γ-H2AX, a DNA damage biomarker, and pathological complete response in triple-negative breast cancer.

Breast cancer "tailored follow-up" in Italian oncology units: a web-based survey

Breast cancer follow-up strategies in randomized phase III adjuvant clinical trials: a systematic review

Changes of topoisomerase IIalpha expression in breast tumors after neoadjuvant chemotherapy predicts relapse-free survival.

Chemotherapy-induced nausea and vomiting in Italian cancer centers: results of CINVDAY, a prospective, multicenter study

Circulating Cancer Stem Cell-Derived Extracellular Vesicles as a Novel Biomarker for Clinical Outcome Evaluation

Circulating autoantibodies to LGALS3BP: a novel biomarker for cancer

Circulating immunostimulatory protein 90K and soluble interleukin-2-receptor in human ovarian cancer

Combination of peripheral neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio is predictive of pathological complete response after neoadjuvant chemotherapy in breast cancer patients

Combinations of biological response modifiers: rationale and clinical responses

Comparison between CaGene 5.1 and 6.0 for BRCA1/2 mutation prediction: a retrospective study of 150 BRCA1/2 genetic tests in 517 families with breast/ovarian cancer.

Corrigendum to "Circulating Cancer Stem Cell-Derived Extracellular Vesicles as a Novel Biomarker for Clinical Outcome Evaluation"

Cyclooxygenase-independent induction of p21WAF-1/cip1, apoptosis and differentiation by L-745,337, a selective PGH synthase-2 inhibitor, and salicylate in HT-29 cells

DNA and S-phase fraction analysis by flow cytometry in prostate cancer. Clinicopathologic implications

DNA ploidy and S-phase fraction in pulmonary carcinoids

Differential effect on TCR:CD3 stimulation of a 90-kD glycoprotein (gp90/Mac-2BP), a member of the scavenger receptor cysteine-rich domain protein family

Distinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+ breast cancer and degree of benefit from novel anti-HER2 agents in the real world setting

Dynamic test with recombinant interferon-alpha-2b: effect on 90K and other tumour-associated antigens in cancer patients without evidence of disease.

Effect of targeted agents on the endocrine response of breast cancer in the neoadjuvant setting: a systematic review

Effect of thyroid hormones on androgen responsiveness in a mammary tumor cell line

Effectiveness and response predictive factors of erlotinib in a non-small cell lung cancer unselected European population previously treated: a retrospective, observational, multicentric study

Effectiveness of neoadjuvant trastuzumab and chemotherapy in HER2-overexpressing breast cancer

Effects of repurposed drug candidates nitroxoline and nelfinavir as single agents or in combination with erlotinib in pancreatic cancer cells

Effects of type-I and -II interferons on 90K antigen expression in ovarian carcinoma cells

Elevated serum levels of 90K/MAC-2 BP predict unresponsiveness to alpha-interferon therapy in chronic HCV hepatitis patients.

Eribulin in Triple Negative Metastatic Breast Cancer: Critic Interpretation of Current Evidence and Projection for Future Scenarios

Estrogen binding by neoplastic human thymus cytosol

Expression of glycoprotein 90K in human malignant pleural mesothelioma: correlation with patient survival.

Expression of the 90K Tumor-Associated Protein in Benign and Malignant Melanocytic Lesions

Extraordinary and prolonged erlotinib-induced clinical response in a patient with EGFR wild-type squamous lung cancer in third-line therapy: a case report.

Family history of cancer as surrogate predictor for immunotherapy with anti-PD1/PD-L1 agents: preliminary report of the FAMI-L1 study

Fulvestrant 500 milligrams as endocrine therapy for endocrine sensitive advanced breast cancer patients in the real world: the Ful500 prospective observational trial.

Galectin-3 overexpression protects from apoptosis by improving cell adhesion properties

Galectin-3 overexpression protects from cell damage and death by influencing mitochondrial homeostasis.

Galectins and their ligands: amplifiers, silencers or tuners of the inflammatory response?

Growth promoting influences of estradiol, epidermal growth factor, and insulin on human breast cancer: Evidence for differential mechanism of action on tumor cells in vitro

Gynaecomastia with cimetidine

High expression of 90K (Mac-2 BP) is associated with poor survival in node-negative breast cancer patients not receiving adjuvant systemic therapies

Human milk 90K (Mac-2 BP): possible protective effects against acute respiratory infections

Identification of subgroups of early breast cancer patients at high risk of nonadherence to adjuvant hormone therapy: results of an Italian survey

Impact of BMI on HER2+ metastatic breast cancer patients treated with pertuzumab and/or trastuzumab emtansine. Real-world evidence

Inhibition of tumor growth and angiogenesis by SP-2, an anti-lectin, galactoside-binding soluble 3 binding protein (LGALS3BP) antibody

Interleukin-30 Promotes Breast Cancer Growth and Progression

Is the skin a sanctuary for breast cancer cells during treatment with anti-HER2 antibodies?

Lack of Expression of Galectin-3 Is Associated With a Poor Outcome in Node-Negative Patients With Laryngeal Squamous-Cell Carcinoma

Lack of mother-to-child HIV-1 transmission is associated with elevated serum levels of 90 K immune modulatory protein

Long-term outcome of breast cancer patients with pathologic N3a lymph node stage.

Long-term outcome of neoadjuvant endocrine therapy with aromatase inhibitors in elderly women with hormone receptor-positive breast cancer.

Long-term outcome of neoadjuvant systemic therapy for locally advanced breast cancer in routine clinical practice

Long-term performance of risk scores for venous thromboembolism in ambulatory cancer patients

Measurement of a breast cancer associated antigen detected by monoclonal antibody SP-2 in sera of cancer patients

Meta-analysis of phase III trials of docetaxel alone or in combination with chemotherapy in metastatic breast cancer

Multicentric retrospective analysis of platinum-pemetrexed regimens as first-line therapy in non-squamous non-small cell lung cancer patients: A "snapshot" from clinical practice.

Neoadjuvant Chemotherapy In Triple-Negative Breast Cancer: A Multicentric Retrospective Observational Study In Real-Life Setting.

Outcomes of HER2-positive early breast cancer patients in the pre-trastuzumab and trastuzumab eras: a real-world multicenter observational analysis. The RETROHER study

PD-L1 expression as predictive biomarker in patients with NSCLC: a pooled analysis

Palbociclib plus endocrine therapy in HER2 negative, hormonal receptor-positive, advanced breast cancer: A real-world experience

Predictive significance of DNA damage and repair biomarkers in triple-negative breast cancer patients treated with neoadjuvant chemotherapy: An exploratory analysis

Prognostic Value of a Novel Interferon-inducible 90K Tumor Antigen

Prognostic relevance of DNA damage and repair biomarkers in elderly patients with hormone-receptor-positive breast cancer treated with neoadjuvant hormone therapy: evidence from the real-world setting

Prognostic significance of K-Ras mutation rate in metastatic colorectal cancer patients.